Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Wilmington Healthcare makes new senior appointment

October 31, 2017 |  

Healthcare intelligence provider Wilmington Healthcare, which incorporates Binley’s, NHiS, Wellards and HSJ, has promoted a longstanding employee, Shelley Jessop, to the role of Account Director.

Shelley who has worked for Wilmington Healthcare brands since graduating from university 17 years ago, will be overseeing a number of key accounts and ensuring that the specialist teams meet their objectives.  

Shelley’s most recent post at Wilmington Healthcare was Business Development Director, responsible for all aspects of the sales cycle from identifying new opportunities to negotiating and closing deals.  

Prior to that, Shelley was a sales consultant for Wilmington Healthcare’s NHiS Insight team, which provides business intelligence and insight solutions to the pharma industry.  

Other posts that Shelley has held for Wilmington Healthcare companies include Business Development Manager and Assistant Research Manager for Binley’s, which provides healthcare data and intelligence to pharma.        

Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Shelley has enjoyed a long and successful career with Wilmington Healthcare’s brands. I am very pleased to promote her to the role of account director. I know that she will continue to build on the strong relationships she has with her clients and be an extremely valuable asset to our expanding business.” 

- PMLiVE

                                                                                   Ends   

This content was provided by Wilmington Healthcare

Company Details

Wilmington Healthcare

Wilmington Healthcare

Email
Website

 Latest Content from  Wilmington Healthcare 

Hear from her: Women's Health Faces Some Difficult Headwinds. Here's How We Can Move Forward

Considering a portfolio review?

Are you considering a portfolio review for your established pharmaceutical brands? Wondering if you should put some activity behind them? At CHASE our experienced team will ensure you maximise your...

UNDERSTANDING THE ROLE OF PLACE WITHIN THE NEW NHS: FIVE THINGS INDUSTRY NEEDS TO KNOW

Operating a level below system, “place” is an increasingly important unit of NHS organisation, yet it remains an evolving concept that is not always well-understood among industry practitioners. In this...

MISSION CRITICAL: HOW PHARMA CAN HELP THE NHS IMPROVE CARE FOR OLDER PEOPLE

With around two-thirds of all hospital beds occupied by over-65s, the care of older patients has long been recognised as key to the sustainability of the NHS. So how is...

ALL CHANGE FOR SPECIALISED COMMISSIONING: FOUR THINGS INDUSTRY NEEDS TO KNOW ABOUT THE LATEST REFORMS

With a recent NHSEI policy document confirming that a major shake-up of arrangements for Specialised Commissioning is imminent, Oli Hudson, Content Director at Wilmington Healthcare (wilmingtonhealthcare.com), describes the key changes...

HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW

Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to...

ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE

With the Health and Care Act safely passed, Oli Hudson introduces six key stakeholders that will loom large in the new landscape.

Spending on anti-depressants soars as the pandemic’s effect on NHS prescribing patterns is revealed

Wilmington Healthcare’s State of the Nation prescribing report shows that spending on sertraline, commonly used to treat depression and anxiety, increased by 305.5% between 2019/20 and 2020/21 while overall spend...

EQUAL FOOTING: HOW PHARMA CAN HELP THE NHS TO ACT ON HEALTH INEQUALITIES

As the NHS puts a renewed focus on reducing health inequalities, Oli Hudson looks at what opportunities this might it bring for Industry and how it can best play its...

UNDERSTANDING THE NEW VALUE PROPOSITION FOR THE NHS

Industry needs a new way of describing its commercial propositions in response to the changing NHS landscape, argues Wilmington Healthcare’s Oli Hudson. This ‘new value proposition’ needs to be reflected...